Net Loss of Krebs Biochemicals & Industries reported to Rs 6.14 crore in the quarter ended September 2025 as against net loss of Rs 5.76 crore during the previous quarter ended September 2024. Sales declined 67.57% to Rs 4.17 crore in the quarter ended September 2025 as against Rs 12.86 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4.1712.86 -68 OPM %-67.15-21.15 - PBDT-4.52-4.05 -12 PBT-6.14-5.76 -7 NP-6.14-5.76 -7 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 4 November 2025.Powered by Capital Market - Live News

Krebs Biochemicals & Industries announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.32 crore in the quarter ended June 2025 as against net loss of Rs 5.17 crore during the previous quarter ended June 2024. Sales declined 57.49% to Rs 5.48 crore in the quarter ended June 2025 as against Rs 12.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales5.4812.89 -57 OPM %-37.96-16.99 - PBDT-3.72-3.48 -7 PBT-5.32-5.17 -3 NP-5.32-5.17 -3 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live News